Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lu Wang
Institution:
First Affiliated Hospital of Xi'an Jiaotong University
Observed institutions:
First Affiliated Hospital of Xi'an Jiaotong University,
Xiangya Hospital Central South University,
Xi'an Jiaotong University
ORCID:
0009-0004-8704-9153
Observed ORCID:
0009-0004-8704-9153
OpenAlex ID:
A5068729600
Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2023
·
Ruiyun Zhang
, Jingyu Zang
, et al.
·
Clinical Cancer Research
·
39
Serum proteomics identifies S100A11 and MMP9 as novel biomarkers for predicting the early efficacy of sublingual immunotherapy in allergic rhinitis
2023
·
Yongquan Zhang
, Jian Shui
, et al.
·
International Immunopharmacology
·
11
Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2025
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Figure S1-S6 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2025
·
Ruiyun Zhang
, Jingyu Zang
, et al.
PDF
Supplementary Information 1 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2025
·
Ruiyun Zhang
, Jingyu Zang
, et al.
PDF
Table S1-S8 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Figure S1-S6 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Supplementary Information 1 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Figure S1-S6 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Supplementary Information 1 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
PDF
Data from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Table S1-S8 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Data from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2023
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Supplementary Information 1 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2023
·
Ruiyun Zhang
, Jingyu Zang
, et al.
PDF
Data from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2023
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Figure S1-S6 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2023
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2023
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Figure S1-S6 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2023
·
Ruiyun Zhang
, Jingyu Zang
, et al.
PDF
Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2023
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Show more works
View as search
Works count:
19
Citation count:
50
H-index:
2
I10-index:
2
Year
Topic
Type